A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism.

Young Hee SungJoong-Seok KimSang-Won YooNa-Young ShinYoonho NamTae-Beom AhnDallah YooKyung Mi LeeHyug-Gi KimSeong-Beom KohJinhee KimIlsoo KimDo-Young KwonYounghen LeeChulhan KimSun Ju ChungSungyang JoSeung Hyun LeeSang Joon KimMinjae KimChul Hyoung LyooMin Seok BaekSuk Yun KangSuk Ki ChangSang-Won JoSeun Ah LeeHyeo-Il MaYoung Eun KimEun Soo KimYun Joong KimHyun Sook KimMin-Hee WooHye Jeong ChoiEung Yeop Kim

Published in: European radiology (2022)

• Susceptibility map-weighted imaging helps clinicians to predict nigrostriatal degeneration. • The protocol for susceptibility map-weighted imaging can be standardised across MRI vendors. • Susceptibility map-weighted imaging showed diagnostic performance comparable to that of dopamine transporter PET in a multi-centre setting with various MRI scanners.

Keyphrases

contrast enhanced
magnetic resonance imaging
magnetic resonance
high resolution
computed tomography
diffusion weighted imaging
network analysis
randomized controlled trial
mass spectrometry
metabolic syndrome
palliative care
pet ct
drug induced
pet imaging
uric acid
prefrontal cortex